| abstract |
The present invention provides anti-glyco-MUC1 antibodies and antigen-binding fragments thereof that specifically bind to a specific MUC1 cancer-specific glycosylation variant, and fusion proteins and antibody-drug conjugates. associated, as well as nucleic acids encoding such biomolecules. The present invention further relates to the use of antibodies, antigen-binding fragments, fusion proteins, antibody-drug conjugates, and nucleic acids for the treatment of cancer. |